Wayne Shi
Country Lead and Head of General Medicines, Sanofi Greater China
Country Lead and Head of General Medicines, Sanofi Greater China
Wayne Shi is Country Lead and Head of General Medicines for Sanofi Greater China since August 2022. Wayne and his team are fully dedicated to making a positive impact on people’s lives by accelerating the introduction of innovative medicines and making Sanofi’s products accessible to the broadest base of the Chinese population. He is strongly focused on driving digitalization and the go-to-market transformation to best serve the evolving needs of China healthcare, as well as empowering people to bring their best to the workplace.
Prior to joining Sanofi, Wayne was President of Organon China, where he successfully led the Merck-Organon spin off project and worked closely with customers, and different stakeholders from industry and academia to create a sustainable eco-system for China Rx retail business.
Wayne has a deep knowledge of the Chinese healthcare ecosystem. He started his career in the late 1990’s and has held several positions with increasing responsibilities in international pharmaceutical companies including General Manager for AstraZeneca Hong Kong and Head of Sales and Business Unit Head at MSD China. Besides his root in China, Wayne’s experience in the U.K. in a global marketing role brought him deep insight on how Global and Country organisation best collaborate to achieve results.
Wayne has a bachelor of Traditional Chinese Medicine from the Nanjing University of Traditional Chinese Medicine, China and a Master of Business Management from the Olin Business School, Washington University of St. Louis, United States. Wayne is an active Board Member of RDPAC (R&D-based Pharmaceutical Association of China).
Wayne is of Chinese nationality and based in Shanghai.